These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34545041)

  • 1. Biological therapies, asthma and coronavirus disease 2019.
    Ribeiro A; Aguiar R; Morais-Almeida M
    Curr Opin Allergy Clin Immunol; 2021 Dec; 21(6):597-601. PubMed ID: 34545041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe asthma in the era of COVID-19: A narrative review.
    Gaspar-Marques J; van Zeller M; Carreiro-Martins P; Chaves Loureiro C
    Pulmonology; 2022; 28(1):34-43. PubMed ID: 34053902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence following guidelines: Another COVID-19 paradox.
    Heymann WR
    J Am Acad Dermatol; 2021 Jan; 84(1):37-38. PubMed ID: 33130184
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID, Biologics, and Psoriasis Therapy.
    Elston DM
    J Am Acad Dermatol; 2020 Dec; 83(6):1577-1578. PubMed ID: 33051006
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence.
    Adir Y; Humbert M; Saliba W
    J Allergy Clin Immunol; 2021 Aug; 148(2):361-367.e13. PubMed ID: 34144110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics.
    Papaioannou AI; Fouka E; Tzanakis N; Antoniou K; Samitas K; Zervas E; Kostikas K; Bartziokas K; Porpodis K; Papakosta D; Tzouvelekis A; Gerogianni I; Kotsiou O; Makris M; Rovina N; Vlachou G; Markatos M; Vittorakis S; Katsoulis K; Papanikolaou I; Afthinos A; Katsaounou P; Steiropoulos P; Latsios D; Dimakou K; Koukidou S; Hillas G; Tryfon S; Kallieri M; Georgopoulou A; Avarlis P; Bakakos P; Markopoulou K; Gaki E; Paspala A; Kyriakaki Z; Gourgoulianis KI; Papiris S; Loukides S
    J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2588-2595. PubMed ID: 35752436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asthma, severe acute respiratory syndrome coronavirus-2 and coronavirus disease 2019.
    Timberlake DT; Strothman K; Grayson MH
    Curr Opin Allergy Clin Immunol; 2021 Apr; 21(2):182-187. PubMed ID: 33399389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy.
    Molinelli E; Diotallevi F; Simonetti O; Brisigotti V; Sapigni C; Radi G; Campanati A; Offidani A
    Dermatol Ther; 2020 Nov; 33(6):e14256. PubMed ID: 32860474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Inflammation, Immunomodulation and Therapeutic Repair in Current Clinical Trials for the Management of COVID-19.
    Li C; Zhao H; Cheng L; Wang B
    Drug Des Devel Ther; 2021; 15():1345-1356. PubMed ID: 33824579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asthma and severe acute respiratory syndrome coronavirus 2019: current evidence and knowledge gaps.
    Assaf SM; Tarasevych SP; Diamant Z; Hanania NA
    Curr Opin Pulm Med; 2021 Jan; 27(1):45-53. PubMed ID: 33065601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of biologics in severe asthmatic patients with SARS-CoV-2 infection: A prospective study.
    Manti S; Giallongo A; Pecora G; Parisi GF; Papale M; Mulè E; Aloisio D; Rotolo N; Leonardi S
    Pediatr Pulmonol; 2023 Apr; 58(4):1085-1091. PubMed ID: 36593591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
    Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asthma-associated risk for COVID-19 development.
    Skevaki C; Karsonova A; Karaulov A; Xie M; Renz H
    J Allergy Clin Immunol; 2020 Dec; 146(6):1295-1301. PubMed ID: 33002516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection risk of dermatologic therapeutics during the COVID-19 pandemic: an evidence-based recalibration.
    Ghazawi FM; Lim M; Dutz JP; Kirchhof MG
    Int J Dermatol; 2020 Sep; 59(9):1043-1056. PubMed ID: 32621284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 in Children with Asthma.
    Chatziparasidis G; Kantar A
    Lung; 2021 Feb; 199(1):7-12. PubMed ID: 33496842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in clinical outcomes: What we have learned during the COVID-19 pandemic.
    Al-Musa A; LaBere B; Habiballah S; Nguyen AA; Chou J
    J Allergy Clin Immunol; 2022 Feb; 149(2):569-578. PubMed ID: 34958811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asthma and COVID-19: an update.
    Adir Y; Saliba W; Beurnier A; Humbert M
    Eur Respir Rev; 2021 Dec; 30(162):. PubMed ID: 34911694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 in patients with severe asthma using biological agents.
    Aksu K; Demir Ş; Topel M; Yeşilkaya S; Ateş H; Koca Kalkan İ; Öncül A; Çuhadar Erçelebi D; Türkyılmaz S
    Tuberk Toraks; 2021 Sep; 69(3):433-436. PubMed ID: 34581170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities.
    Bienvenu LA; Noonan J; Wang X; Peter K
    Cardiovasc Res; 2020 Dec; 116(14):2197-2206. PubMed ID: 33063089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 in Immunocompromised Patients: A Systematic Review.
    Stainer A; Amati F; Suigo G; Simonetta E; Gramegna A; Voza A; Aliberti S
    Semin Respir Crit Care Med; 2021 Dec; 42(6):839-858. PubMed ID: 34918325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.